EP2830593
RNA-efnablanda í ónæmismeðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.3.2013EP published:
27.2.2019EP application number:
13713356.7
EP translation filed:
1.4.2019Grant published:
15.4.2019EPO information:
European Patent Register
Max expiry date:
24.3.2033Expiry date:
24.3.2027Next due date:
31.3.2027
Title:
RNA FORMULATION FOR IMMUNOTHERAPY
Timeline
Today
25.3.2013EP application
27.2.2019EP Publication
1.4.2019Translation submitted
15.4.2019Registration published
24.3.2027Expires
Owner
Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbHAddress:
Freiligrathstrasse 12, 55131, Mainz, DE
Name:
BioNTech SEAddress:
An der Goldgrube 12, 55131, Mainz, DE
Inventor
Name:
SAHIN, UgurAddress:
Mainz, DE
Name:
HAAS, HeinrichAddress:
Mainz, DE
Name:
KREITER, SebastianAddress:
Mainz, DE
Name:
DIKEN, MustafaAddress:
Mainz, DE
Name:
FRITZ, DanielAddress:
Mainz, DE
Name:
MENG, MartinAddress:
Mainz, DE
Name:
KRANZ, Lena, MareenAddress:
Mainz, DE
Name:
REUTER, KerstinAddress:
Darmstadt, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2012/001319Date:
26.3.2012Country:
WO
Classification
Categories:
A61K 9/127, A61K 39/00, A61K 48/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 29.3.2019
Expires: 24.3.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 8
Paid: 19.3.2020
Expires: 24.3.2021
Payer: Patice ehf.
Number: 9
Paid: 18.3.2021
Expires: 24.3.2022
Payer: Patice ehf.
Number: 10
Paid: 17.3.2022
Expires: 24.3.2023
Payer: Patice ehf.
Number: 11
Paid: 22.2.2023
Expires: 24.3.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 6.3.2024
Expires: 24.3.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.3.2025
Expires: 24.3.2026
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.3.2026
Expires: 24.3.2027
Payer: Árnason Faktor ehf.